Eli Lilly Corp. buy BMO Capital Markets
Start price
01.05.24
/
50%
€726.70
Target price
01.05.25
€936.94
Performance (%)
2.20%
Price
26.07.24
€741.50
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 2.20%. Dividends of €1.19 are taken into consideration when calculating the performance. This prediction currently runs until 01.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | -5.996% | -5.996% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at BMO Capital Markets from $900.00 to $1,001.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-11.94%
26.07.24
26.07.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
11.70%
26.07.24
26.07.24